U.S. flag

An official website of the United States government

NM_000016.6(ACADM):c.1150G>T (p.Glu384Ter) AND Medium-chain acyl-coenzyme A dehydrogenase deficiency

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Nov 2, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000411952.9

Allele description [Variation Report for NM_000016.6(ACADM):c.1150G>T (p.Glu384Ter)]

NM_000016.6(ACADM):c.1150G>T (p.Glu384Ter)

Gene:
ACADM:acyl-CoA dehydrogenase medium chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p31.1
Genomic location:
Preferred name:
NM_000016.6(ACADM):c.1150G>T (p.Glu384Ter)
HGVS:
  • NC_000001.11:g.75761326G>T
  • NG_007045.2:g.41969G>T
  • NM_000016.6:c.1150G>TMANE SELECT
  • NM_001127328.3:c.1162G>T
  • NM_001286042.2:c.1042G>T
  • NM_001286043.2:c.1249G>T
  • NM_001286044.2:c.583G>T
  • NP_000007.1:p.Glu384Ter
  • NP_000007.1:p.Glu384Ter
  • NP_001120800.1:p.Glu388Ter
  • NP_001272971.1:p.Glu348Ter
  • NP_001272972.1:p.Glu417Ter
  • NP_001272973.1:p.Glu195Ter
  • LRG_838t1:c.1150G>T
  • LRG_838:g.41969G>T
  • LRG_838p1:p.Glu384Ter
  • NC_000001.10:g.76227011G>T
  • NM_000016.4:c.1150G>T
  • NM_000016.5:c.1150G>T
Protein change:
E195*
Links:
dbSNP: rs748110745
NCBI 1000 Genomes Browser:
rs748110745
Molecular consequence:
  • NM_000016.6:c.1150G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001127328.3:c.1162G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001286042.2:c.1042G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001286043.2:c.1249G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001286044.2:c.583G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Medium-chain acyl-coenzyme A dehydrogenase deficiency (ACADMD)
Synonyms:
CARNITINE DEFICIENCY SECONDARY TO MEDIUM-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY; MCADD; Medium chain acyl-CoA dehydrogenase deficiency
Identifiers:
MONDO: MONDO:0008721; MedGen: C0220710; Orphanet: 42; OMIM: 201450

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000486618Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Likely pathogenic
(Jul 8, 2016)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf,

Citation Link,

SCV001206380Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 2, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Disease-causing mutations in exon 11 of the medium-chain acyl-CoA dehydrogenase gene.

Andresen BS, Jensen TG, Bross P, Knudsen I, Winter V, Kølvraa S, Bolund L, Ding JH, Chen YT, Van Hove JL, et al.

Am J Hum Genet. 1994 Jun;54(6):975-88.

PubMed [citation]
PMID:
8198141
PMCID:
PMC1918184

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Counsyl, SCV000486618.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001206380.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change creates a premature translational stop signal (p.Glu384*) in the ACADM gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 38 amino acid(s) of the ACADM protein. This variant is present in population databases (rs748110745, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with MCAD deficiency (PMID: 8198141). ClinVar contains an entry for this variant (Variation ID: 371122). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects ACADM function (PMID: 8198141). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024